Yüklüyor......
Anti-cytokine therapy in fibrosing alveolitis: where are we now?
Idiopathic pulmonary fibrosis (IPF) is a condition that has a poor prognosis, with a median survival of 4-5 years irrespective of treatment. Ziesche et al (N Engl J Med 1999, 341: 1264-1269) describe an open randomised trial of 18 patients with IPF, unresponsive to corticosteroid treatment at high d...
Kaydedildi:
| Yazar: | |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioMed Central
2000
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC59532/ https://ncbi.nlm.nih.gov/pubmed/11667955 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/rr2 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|